Cheongju, South Korea

Jeung Soon Choi

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Legochem Biosciences, Inc.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeung Soon Choi. Retrieved from https://idiyas.com/inventor/jeung-soon-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jeung Soon Choi in Antibacterial Agents

Introduction

Jeung Soon Choi is a notable inventor based in Cheongju-si, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial agents. His work focuses on innovative compositions and methods that target specific bacterial enzymes.

Latest Patents

One of Jeung Soon Choi's key patents is titled "Compositions and methods for inhibiting β-lactamase." This patent introduces substituted dihydroisoxazole derivatives that serve as effective inhibitors of β-lactamases. The invention highlights the medical applications of these derivatives, particularly their use as antibacterial agents. Jeung Soon Choi holds 1 patent in this area.

Career Highlights

Jeung Soon Choi is currently associated with Legochem Biosciences, Inc., where he continues to advance his research in the field of biochemistry. His work has garnered attention for its potential impact on antibiotic resistance and the development of new therapeutic strategies.

Collaborations

Jeung Soon Choi collaborates with talented colleagues, including Hye Kyung Chang and Sung Yoon Baek. Their combined expertise contributes to the innovative research environment at Legochem Biosciences, Inc.

Conclusion

Jeung Soon Choi's contributions to the field of antibacterial agents through his innovative patent work exemplify the importance of research in combating antibiotic resistance. His ongoing efforts at Legochem Biosciences, Inc. continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…